Áttekintés
Árfolyamváltozás megosztása
24 óra
Jelenlegi
Minimum
7.76
Maximum
9.76
Ajánlások | Eladás |
|---|---|
12 hónapos előrejelzés | -12.28% downside |
Következő eredményjelentés | 2026. nov. 5. |
|---|
Hangulat hírek alapján
By Acuity
50%
50%
111 / 339 Rangsor szerint Healthcare
Ginkgo Bioworks Holdings Inc Chart
A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.
Kapcsolódó hírek
2026. szept. 21. 20:06 UTC
Ginkgo Bioworks Holdings Inc is advancing as the broader market remains higher, maintaining an upward trend and trading above its 20-day moving average.
Olvasás
2026. szept. 18. 20:06 UTC
Ginkgo Bioworks Holdings Inc is seeing modest gains, maintaining a position significantly above its 20-day moving average despite fluctuations earlier in the day.
Olvasás
2026. szept. 17. 20:02 UTC
Ginkgo Bioworks shares rise sharply amid notable call options trading, supported by gains in the ARK Genomic Revolution ETF, despite an earlier pullback.
Olvasás
2026. szept. 16. 19:26 UTC
Ginkgo Bioworks announced a partnership with Eli Lilly's TuneLab to enhance drug development efficiency, as shares fell slightly since Tuesday's close.
Olvasás
2026. szept. 15. 20:07 UTC
Ginkgo Bioworks shares are lower, reflecting broader market declines amid negative economic indicators and rising oil prices. Earlier, shares briefly rebounded before pulling back.
Olvasás
2026. szept. 14. 23:06 UTC
Ginkgo Bioworks Holdings Inc shares are lower in after-market hours. The broader market faces pressure from rising crude oil prices amid supply concerns.
Olvasás
2026. szept. 2. 19:56 UTC
Ginkgo Bioworks is gaining traction amid social media discussions on Pfizer and Google announcements, despite a generally negative market environment.
Olvasás
2026. szept. 1. 23:06 UTC
Ginkgo Bioworks shares are higher in after-market trading, reaching a peak above the previous day's close. The stock remains below its 20-day moving average.
Olvasás
2026. aug. 31. 22:16 UTC
Ginkgo Bioworks Holdings Inc is trading higher in after-market hours, influenced by broader market reactions to comments on inflation and interest rate expectations.
Olvasás
2026. aug. 28. 22:02 UTC
Ginkgo Bioworks Holdings Inc shares are higher in after-market trading, continuing a recent trend of daily gains despite no specific news to explain the move.
Olvasás
2026. aug. 26. 20:08 UTC
Ginkgo Bioworks Holdings Inc is lower today, influenced by declines in the Life Sciences Tools & Services sub-sector and trading below its 20-day moving average.
Olvasás
2026. aug. 25. 20:07 UTC
Ginkgo Bioworks shares advance amid positive sentiment linked to Moderna and Merck. Earlier, shares pulled back from a session high but gained traction.
Olvasás
2026. aug. 24. 20:02 UTC
Ginkgo Bioworks shares are lower today amid broader market volatility and geopolitical concerns, with no specific company news identified to explain the decline.
Olvasás
2026. aug. 21. 23:56 UTC
Ginkgo Bioworks Holdings Inc is higher in after-market trading amid a broader market rebound, despite no specific company news identified.
Olvasás
2026. aug. 20. 23:41 UTC
Ginkgo Bioworks Holdings Inc. gained in after-market trading, supported by broader market movements and positive jobless claims data. Shares remain below their 20-day moving average.
Olvasás
2026. aug. 19. 23:51 UTC
Ginkgo Bioworks Holdings Inc shares are lower in after-market trading. The stock is also below its 20-day moving average.
Olvasás
2026. aug. 17. 19:46 UTC
Ginkgo Bioworks is advancing amid positive market sentiment following a rise in New York manufacturing conditions. Shares pulled back slightly after reaching a session high.
Olvasás
2026. aug. 14. 19:46 UTC
Ginkgo Bioworks Holdings Inc shares are lower amid broader market declines following a surprising drop in U.S. retail sales for July.
Olvasás
2026. aug. 11. 20:02 UTC
Ginkgo Bioworks shares are lower, tracking the broader market's decline. The stock remains below its 20-day moving average after four consecutive sessions of losses.
Olvasás
2026. aug. 10. 19:26 UTC
Ginkgo Bioworks reported second-quarter revenue of $20 million, a 48% decline year-over-year. Shares are trading lower, extending a three-day decline.
Olvasás
2026. aug. 7. 22:26 UTC
Ginkgo Bioworks shares decline in after-market hours following TD Cowen's downgrade to Hold and a price target cut to $9.
Olvasás
2026. aug. 6. 20:02 UTC
Ginkgo Bioworks is down significantly today, continuing a decline since Wednesday's close, despite recent operational improvements and a brief recovery earlier in the session.
Olvasás
2026. aug. 5. 22:51 UTC
Ginkgo Bioworks shares are lower in after-market trading following a revenue miss of $20 million, despite an EPS beat of -$0.92.
Olvasás
2026. aug. 4. 19:46 UTC
Ginkgo Bioworks shares are higher today, continuing a four-session rally, supported by broader market trends and easing inflation concerns from falling crude oil prices.
Olvasás
2026. aug. 3. 20:04 UTC
Ginkgo Bioworks Holdings Inc. is up notably since Friday's close, reflecting strong performance amid broader market gains, despite a slight pullback earlier in the session.
Olvasás
2026. júl. 31. 23:16 UTC
Ginkgo Bioworks shares are lower in after-market hours, reflecting broader market weakness and challenges in the specialty chemicals sector.
Olvasás
2026. júl. 29. 19:47 UTC
Ginkgo Bioworks has signed a $2.3 million deal with Thermo Fisher for 11 chips. Shares are declining amid broader market weakness and economic uncertainties.
Olvasás
2026. júl. 28. 22:46 UTC
Ginkgo Bioworks Holdings Inc. shares are lower in after-market hours, continuing a downward trend amid broader market weakness ahead of the Federal Reserve's policy meeting.
Olvasás
2026. júl. 27. 20:51 UTC
Ginkgo Bioworks shares are higher in after-market hours, supported by broader market trends as European indices, including the DAX, also rise.
Olvasás
2026. júl. 24. 19:07 UTC
Ginkgo Bioworks participates in the $400 million Genesis Mission but shares are lower amid broader market declines influenced by falling crude oil prices.
Olvasás
Társak összehasonlítása
Árváltozás
Ginkgo Bioworks Holdings Inc Előrejelzés
Célár
By TipRanks
12 hónapos előrejelzés
Átlag 7 USD -12.28%
Magas 9 USD
Alacsony 5 USD
3 Wall Street elemző 12 hónapos célárain alapulva a(z)Ginkgo Bioworks Holdings Inc termékhez az elmúlt 3 hónapban.
Értékelési konszenzus
By TipRanks
Eladás
3 ratings
0
Vétel
1
Tartás
2
Eladás
3 Wall Street elemző célárain alapulva a(z)Ginkgo Bioworks Holdings Inc termékhez az elmúlt 3 hónapban.
Hangulat
By Acuity
Hangulat hírek alapján
Neutral
Volatilitás
Átlag alatti
Hírmennyiség (RCV)
Átlag
Pénzügyek
$